Return 3395
Application:51001, Using Mendelian randomization to infer health effects of cardiovascular and diabetes medication in the UK Biobank
Title:Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study
Size:6.0 MB
Archived:29 Apr 2021
Personal:Contains individual-level data